Neoadjuvant therapy in early breast cancer: treatment considerations and common debates in practice

Cain, H., MacPherson, I.R. , Beresford, M., Pinder, S.E., Pong, J. and Dixon, J.M. (2017) Neoadjuvant therapy in early breast cancer: treatment considerations and common debates in practice. Clinical Oncology, 29(10), pp. 642-652. (doi: 10.1016/j.clon.2017.06.003) (PMID:28669449)

[img]
Preview
Text
143572.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

1MB

Abstract

Neoadjuvant treatment offers a number of benefits for patients with early breast cancer, and is an important option for consideration by multidisciplinary teams. Despite literature showing its efficacy, the use of neoadjuvant therapy varies widely. Here we discuss the clinical evidence supporting the use of neoadjuvant therapy in early stage breast cancer, including patient selection, monitoring response, surgery and radiotherapy considerations, with the aim of assisting multidisciplinary teams to determine patient suitability for neoadjuvant treatment.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:MacPherson, Professor Iain
Authors: Cain, H., MacPherson, I.R., Beresford, M., Pinder, S.E., Pong, J., and Dixon, J.M.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Clinical Oncology
Publisher:Elsevier
ISSN:0936-6555
ISSN (Online):1433-2981
Published Online:29 June 2017
Copyright Holders:Copyright © 2017 The Royal College of Radiologists
First Published:First published in Clinical Oncology 29(10): 642-652
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record